Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

'Corrigendum to "Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia" [Molecular Metabolism 5 (2) (2015) 67-78]'.

Autor: Schäfer M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany., Oeing CU; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany., Rohm M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany., Baysal-Temel E; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany., Lehmann LH; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany., Bauer R; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany., Volz HC; Division of Signaling and Functional Genomics, German Cancer, Research Center (DKFZ), 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany., Boutros M; Division of Signaling and Functional Genomics, German Cancer, Research Center (DKFZ), 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany., Sohn D; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany., Sticht C; Center for Medical Research, University of Mannheim, 68167, Mannheim, Germany., Gretz N; Center for Medical Research, University of Mannheim, 68167, Mannheim, Germany., Eichelbaum K; Department for Cell Signaling and Mass Spectrometry, Max Delbrück Center, 13092, Berlin, Germany., Werner T; Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany., Hirt MN; Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany., Eschenhagen T; Department of Experimental and Clinical Pharmacology and Toxicology, University Medical Center, 20246, Hamburg-Eppendorf, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Hamburg/Kiel/Lübeck, 20246, Hamburg-Eppendorf, Germany., Müller-Decker K; Core Facility Tumor Models, German Cancer Research Center (DKFZ), 69120, Heidelberg, Germany., Strobel O; Department of, General Surgery, University of Heidelberg, 69120, Heidelberg, Germany., Hackert T; Department of, General Surgery, University of Heidelberg, 69120, Heidelberg, Germany., Krijgsveld J; Genome Biology Unit, EMBL, 69117, Heidelberg, Germany., Katus HA; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany., Berriel Diaz M; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany., Backs J; Department of Cardiology, Angiology and Pulmonology, University Hospital Heidelberg, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; Department of Molecular Cardiology and Epigenetics, University Hospital Heidelberg, 69120, Heidelberg, Germany. Electronic address: johannes.backs@med.uni-heidelberg.de., Herzig S; Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, 85764, Neuherberg, Germany; Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, 69120, Heidelberg, Germany; DZHK (German Centre for Cardiovascular Research), Partner site Heidelberg/Mannheim, 69120, Heidelberg, Germany; German Center for Diabetes Research (DZD), 85764, Neuherberg, Germany. Electronic address: stephan.herzig@helmholtz-muenchen.de.

Publikováno v: Molecular metabolism [Mol Metab] 2020 May; Vol. 35, pp. 100970. Date of Electronic Publication: 2020 Mar 04.